Larvol Delta - AR882-selective-uric-acid-transporter-1-URAT1-inhibitor-in-development-completed-a-phase-2-140-pt-12week-PBO-controlled-trial-where-75-mgd-lowered-SUA-by-59-86-to-35--amp-42-86-to-50--in-50-mg-dose-group--all-better-than-PBO-httpstcoHHzHWj4XQr

AR882 - Arthrosi

Jan 16, 2023